Investigation of Pathogenic and Truncated Variants of RUNX1 and DDX41 in All of Us
Cancer Genomics Consortium via YouTube
Pass the PMP® Exam on Your First Try — Expert-Led Training
The Fastest Way to Become a Backend Developer Online
Overview
Build a Learning Habit
Download Class Central's free printable study calendar
Download for Free
Explore a comprehensive investigation into pathogenic and truncated variants of RUNX1 and DDX41 genes within the All of Us research program. Presented by Huan Mo at the Cancer Genomics Consortium (CGC) 2023 Annual Meeting, this 11-minute conference talk delves into the significance of these genetic variations in cancer genomics. Learn about the latest findings and their potential impact on accurate cancer diagnosis and personalized treatment strategies. Gain insights into the collaborative efforts of clinical cytogeneticists, molecular geneticists, and molecular pathologists in advancing cancer genomics research and clinical practice.
Syllabus
Investigation of pathogenic and truncated variants of RUNX1 and DDX41 in All of Us
Taught by
Cancer Genomics Consortium